Studies determining the effects of activated charcoal on drug absorption frequently use area under the plasma drug concentration versus time curve or drug and metabolite recovery in the urine as endpoints. The considerations in using these endpoints is presented using studies that have evaluated the effects of activated charcoal on acetylcysteine absorption. Acetylcysteine's pharmacokinetics, quantitation of plasma concentrations, and the lack of an identifiable pharmacokinetic-pharmacodynamic relationship all contribute to the difficulties in determining whether activated charcoal inhibits the oral absorption of acetylcysteine, or alters acetylcysteine's efficacy in treating acetaminophen overdoses. The results of these studies should be interpreted cautiously, with consideration of internal and external study validity.
Get full access to this article
View all access options for this article.
References
1.
NeuvonenPJOlkkolaKT. Oral activated charcoal in the treatment of intoxications—role of single and repeated doses. Med Toxicol1988; 3: 33–58.
2.
KrenzelokEPHellerMB. Effectiveness of commercially available aqueous activated charcoal products. Ann Emerg Med1987; 16: 1349–5.
3.
DillonECWiltonJCBarlowJCWatsonWA. Large surface area activated charcoal and the inhibition of aspirin absorption. Ann Emerg Med1989; 18: 547–52.
4.
KrenzelokEP. Use of activated charcoal (letter). Ann Emerg Med1986; 15: 102.
5.
DonovanJW. Use of activated charcoal (letter). Ann Emerg Med1986; 15: 102.
6.
BlakeKVZientekGMHendelesL. Death of a child associated with multiple overdoses of acetaminophen. Clin Pharm1988; 7: 391–7.
LevyGHoustonJB. Effect of activated charcoal on acetaminophen absorption. Pediatrics1976; 58: 432–5.
9.
ChinouthRWCzajaPAPetersonRG. N-acetylcysteine adsorption by activated charcoal. Vet Hum Toxicol1980; 22: 392–4.
10.
RyboltTRBurrellDEShultsJMKelleyAK. In vitro coadsorption of acetaminophen and N-acetylcysteine onto activated carbon powder. J Pharm Sci1986; 75: 904–6.
11.
Klein-SchwartzWOderdaGM. Adsorption of oral antidotes for acetaminophen poisoning (methionine and N-acetylcysteine) by activated charcoal. Clin Toxicol1981; 18: 283–90.
12.
RenziFPDonovanJMartinTGMorganLHarrisonEF. Concomitant use of activated charcoal and N-acetylcysteine. Ann Emerg Med1985; 14: 568–72.
13.
EkinsBRFordDCThompsonMIBBridgesRRRollinsDEJenkinsRD. The effect of activated charcoal on N-acetylcysteine absorption in normal subjects. Am J Emerg Med1987; 5: 483–7.
14.
NorthDSPetersonRGKrenzelokEP. Effect of activated charcoal administration on acetylcysteine serum levels in humans. Am J Hosp Pharm1981; 38: 1022–4.
15.
ChamberlainJMGormanRLOderdaGMKlein-SchwartzWKleinBL. The use of activated charcoal in a simulated poisoning with acetaminophen: A new loading dose for N-acetylcysteine? (abstract)Vet Hum Toxical1990; 32: 346.
16.
KramerMSShapiroSH. Scientific challenges in the applications of randomized trials. JAMA1984; 252: 2739–45.
17.
BrentJRumackBH. Acetaminophen poisoning. In: Harwood-NussALindenCLuttenRCSternbackGWolfsonAB, eds. The clinical practice of emergency medicine. Philadelphia: JB Lippincott, 1991: 453–7.
18.
BorgstromLKagedalBPaulsenO. Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol1986; 31: 217–22.
19.
OlssonBJohanssonMGabrielssonJBolmeP. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol1988; 34: 77–82.
20.
WeissM. Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction. Clin Pharmacokinet1990; 18: 419–22.
21.
BonanomiLGazzanigaA. Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur J Respir Dis1980; 61 (suppl 111): 45–51.
22.
RodensteinDDe CosterAGazzanigaA. Pharmacokinetics of oral acetylcysteine: Absorption, binding and metabolism in patients with respiratory disorders. Clin Pharmacokinet1978; 3: 247–54.
23.
MorganLRHoldinessMRGillenLE. N-acetylcysteine: Its bioavailability and interaction with ifosfamide metabolites. Semin Oncol1983; 10 (suppl 1):56–61.
24.
CotgreaveIAMoldeusP. Methodologies for the analysis of reduced and oxidized N-acetylcysteine in biological systems. Biopharm Drug Dispos1987; 8: 365–75.
25.
PipernoEBerssenbrueggeDA. Reversal of experimental paracetamol toxicosis with N-acetylcysteine (letter). Lancet1978; 2: 738–9.
26.
PipernoEMosherAHBerssenbrueggeDAWinklerJDSmithRB. Pathophysiology of acetaminophen overdosage toxicity: Implications for management. Pediatrics1978; 62 (suppl):880–9.
27.
MitchellJR. Acetaminophen toxicity (editorial). N Engl J Med1988; 319: 1601–2.
28.
HamlynANDouglasAPJamesO. The spectrum of paracetamol (acetaminophen) overdose: Clinical and epidemiological studies. Postgrad Med J1978; 54: 400–4.
29.
SmilksteinMJKnappGLKuligKWRumackBH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: Analysis of the national multicenter study (1976–1985). N Engl J Med1988; 319: 1557–62.
30.
RumackBHPetersonRCKochGGAmaraIA. Acetaminophen overdose: 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med1981; 141: 380–5.
31.
Van De GraffWBThompsonWLSunshineIFrettholdDLeicklyFDaytonH. Adsorbent and cathartic inhibition of enteral drug absorption. J Pharmacol Exp Ther1981; 221: 656–63.
32.
RoseSRGormanRLOderdaGMKlein-SchwartzWWatsonWA. Treatment of liquid drug overdoses with activated charcoal (abstract). Vet Hum Toxicol1989; 31: 334.
